Cargando…

Structurally related but genetically unrelated antibody lineages converge on an immunodominant HIV-1 Env neutralizing determinant following trimer immunization

Understanding the molecular mechanisms by which antibodies target and neutralize the HIV-1 envelope glycoprotein (Env) is critical in guiding immunogen design and vaccine development aimed at eliciting cross-reactive neutralizing antibodies (NAbs). Here, we analyzed monoclonal antibodies (mAbs) isol...

Descripción completa

Detalles Bibliográficos
Autores principales: Aljedani, Safia S., Liban, Tyler J., Tran, Karen, Phad, Ganesh, Singh, Suruchi, Dubrovskaya, Viktoriya, Pushparaj, Pradeepa, Martinez-Murillo, Paola, Rodarte, Justas, Mileant, Alex, Mangala Prasad, Vidya, Kinzelman, Rachel, O’Dell, Sijy, Mascola, John R., Lee, Kelly K., Karlsson Hedestam, Gunilla B., Wyatt, Richard T., Pancera, Marie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8494329/
https://www.ncbi.nlm.nih.gov/pubmed/34559844
http://dx.doi.org/10.1371/journal.ppat.1009543
_version_ 1784579288525176832
author Aljedani, Safia S.
Liban, Tyler J.
Tran, Karen
Phad, Ganesh
Singh, Suruchi
Dubrovskaya, Viktoriya
Pushparaj, Pradeepa
Martinez-Murillo, Paola
Rodarte, Justas
Mileant, Alex
Mangala Prasad, Vidya
Kinzelman, Rachel
O’Dell, Sijy
Mascola, John R.
Lee, Kelly K.
Karlsson Hedestam, Gunilla B.
Wyatt, Richard T.
Pancera, Marie
author_facet Aljedani, Safia S.
Liban, Tyler J.
Tran, Karen
Phad, Ganesh
Singh, Suruchi
Dubrovskaya, Viktoriya
Pushparaj, Pradeepa
Martinez-Murillo, Paola
Rodarte, Justas
Mileant, Alex
Mangala Prasad, Vidya
Kinzelman, Rachel
O’Dell, Sijy
Mascola, John R.
Lee, Kelly K.
Karlsson Hedestam, Gunilla B.
Wyatt, Richard T.
Pancera, Marie
author_sort Aljedani, Safia S.
collection PubMed
description Understanding the molecular mechanisms by which antibodies target and neutralize the HIV-1 envelope glycoprotein (Env) is critical in guiding immunogen design and vaccine development aimed at eliciting cross-reactive neutralizing antibodies (NAbs). Here, we analyzed monoclonal antibodies (mAbs) isolated from non-human primates (NHPs) immunized with variants of a native flexibly linked (NFL) HIV-1 Env stabilized trimer derived from the tier 2 clade C 16055 strain. The antibodies displayed neutralizing activity against the autologous virus with potencies ranging from 0.005 to 3.68 μg/ml (IC(50)). Structural characterization using negative-stain EM and X-ray crystallography identified the variable region 2 (V2) of the 16055 NFL trimer to be the common epitope for these antibodies. The crystal structures revealed that the V2 segment adopts a β-hairpin motif identical to that observed in the 16055 NFL crystal structure. These results depict how vaccine-induced antibodies derived from different clonal lineages penetrate through the glycan shield to recognize a hypervariable region within V2 (residues 184–186) that is unique to the 16055 strain. They also provide potential explanations for the potent autologous neutralization of these antibodies, confirming the immunodominance of this site and revealing that multiple angles of approach are permissible for affinity/avidity that results in potent neutralizing capacity. The structural analysis reveals that the most negatively charged paratope correlated with the potency of the mAbs. The atomic level information is of interest to both define the means of autologous neutralization elicited by different tier 2-based immunogens and facilitate trimer redesign to better target more conserved regions of V2 to potentially elicit cross-neutralizing HIV-1 antibodies.
format Online
Article
Text
id pubmed-8494329
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-84943292021-10-07 Structurally related but genetically unrelated antibody lineages converge on an immunodominant HIV-1 Env neutralizing determinant following trimer immunization Aljedani, Safia S. Liban, Tyler J. Tran, Karen Phad, Ganesh Singh, Suruchi Dubrovskaya, Viktoriya Pushparaj, Pradeepa Martinez-Murillo, Paola Rodarte, Justas Mileant, Alex Mangala Prasad, Vidya Kinzelman, Rachel O’Dell, Sijy Mascola, John R. Lee, Kelly K. Karlsson Hedestam, Gunilla B. Wyatt, Richard T. Pancera, Marie PLoS Pathog Research Article Understanding the molecular mechanisms by which antibodies target and neutralize the HIV-1 envelope glycoprotein (Env) is critical in guiding immunogen design and vaccine development aimed at eliciting cross-reactive neutralizing antibodies (NAbs). Here, we analyzed monoclonal antibodies (mAbs) isolated from non-human primates (NHPs) immunized with variants of a native flexibly linked (NFL) HIV-1 Env stabilized trimer derived from the tier 2 clade C 16055 strain. The antibodies displayed neutralizing activity against the autologous virus with potencies ranging from 0.005 to 3.68 μg/ml (IC(50)). Structural characterization using negative-stain EM and X-ray crystallography identified the variable region 2 (V2) of the 16055 NFL trimer to be the common epitope for these antibodies. The crystal structures revealed that the V2 segment adopts a β-hairpin motif identical to that observed in the 16055 NFL crystal structure. These results depict how vaccine-induced antibodies derived from different clonal lineages penetrate through the glycan shield to recognize a hypervariable region within V2 (residues 184–186) that is unique to the 16055 strain. They also provide potential explanations for the potent autologous neutralization of these antibodies, confirming the immunodominance of this site and revealing that multiple angles of approach are permissible for affinity/avidity that results in potent neutralizing capacity. The structural analysis reveals that the most negatively charged paratope correlated with the potency of the mAbs. The atomic level information is of interest to both define the means of autologous neutralization elicited by different tier 2-based immunogens and facilitate trimer redesign to better target more conserved regions of V2 to potentially elicit cross-neutralizing HIV-1 antibodies. Public Library of Science 2021-09-24 /pmc/articles/PMC8494329/ /pubmed/34559844 http://dx.doi.org/10.1371/journal.ppat.1009543 Text en https://creativecommons.org/publicdomain/zero/1.0/This is an open access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 (https://creativecommons.org/publicdomain/zero/1.0/) public domain dedication.
spellingShingle Research Article
Aljedani, Safia S.
Liban, Tyler J.
Tran, Karen
Phad, Ganesh
Singh, Suruchi
Dubrovskaya, Viktoriya
Pushparaj, Pradeepa
Martinez-Murillo, Paola
Rodarte, Justas
Mileant, Alex
Mangala Prasad, Vidya
Kinzelman, Rachel
O’Dell, Sijy
Mascola, John R.
Lee, Kelly K.
Karlsson Hedestam, Gunilla B.
Wyatt, Richard T.
Pancera, Marie
Structurally related but genetically unrelated antibody lineages converge on an immunodominant HIV-1 Env neutralizing determinant following trimer immunization
title Structurally related but genetically unrelated antibody lineages converge on an immunodominant HIV-1 Env neutralizing determinant following trimer immunization
title_full Structurally related but genetically unrelated antibody lineages converge on an immunodominant HIV-1 Env neutralizing determinant following trimer immunization
title_fullStr Structurally related but genetically unrelated antibody lineages converge on an immunodominant HIV-1 Env neutralizing determinant following trimer immunization
title_full_unstemmed Structurally related but genetically unrelated antibody lineages converge on an immunodominant HIV-1 Env neutralizing determinant following trimer immunization
title_short Structurally related but genetically unrelated antibody lineages converge on an immunodominant HIV-1 Env neutralizing determinant following trimer immunization
title_sort structurally related but genetically unrelated antibody lineages converge on an immunodominant hiv-1 env neutralizing determinant following trimer immunization
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8494329/
https://www.ncbi.nlm.nih.gov/pubmed/34559844
http://dx.doi.org/10.1371/journal.ppat.1009543
work_keys_str_mv AT aljedanisafias structurallyrelatedbutgeneticallyunrelatedantibodylineagesconvergeonanimmunodominanthiv1envneutralizingdeterminantfollowingtrimerimmunization
AT libantylerj structurallyrelatedbutgeneticallyunrelatedantibodylineagesconvergeonanimmunodominanthiv1envneutralizingdeterminantfollowingtrimerimmunization
AT trankaren structurallyrelatedbutgeneticallyunrelatedantibodylineagesconvergeonanimmunodominanthiv1envneutralizingdeterminantfollowingtrimerimmunization
AT phadganesh structurallyrelatedbutgeneticallyunrelatedantibodylineagesconvergeonanimmunodominanthiv1envneutralizingdeterminantfollowingtrimerimmunization
AT singhsuruchi structurallyrelatedbutgeneticallyunrelatedantibodylineagesconvergeonanimmunodominanthiv1envneutralizingdeterminantfollowingtrimerimmunization
AT dubrovskayaviktoriya structurallyrelatedbutgeneticallyunrelatedantibodylineagesconvergeonanimmunodominanthiv1envneutralizingdeterminantfollowingtrimerimmunization
AT pushparajpradeepa structurallyrelatedbutgeneticallyunrelatedantibodylineagesconvergeonanimmunodominanthiv1envneutralizingdeterminantfollowingtrimerimmunization
AT martinezmurillopaola structurallyrelatedbutgeneticallyunrelatedantibodylineagesconvergeonanimmunodominanthiv1envneutralizingdeterminantfollowingtrimerimmunization
AT rodartejustas structurallyrelatedbutgeneticallyunrelatedantibodylineagesconvergeonanimmunodominanthiv1envneutralizingdeterminantfollowingtrimerimmunization
AT mileantalex structurallyrelatedbutgeneticallyunrelatedantibodylineagesconvergeonanimmunodominanthiv1envneutralizingdeterminantfollowingtrimerimmunization
AT mangalaprasadvidya structurallyrelatedbutgeneticallyunrelatedantibodylineagesconvergeonanimmunodominanthiv1envneutralizingdeterminantfollowingtrimerimmunization
AT kinzelmanrachel structurallyrelatedbutgeneticallyunrelatedantibodylineagesconvergeonanimmunodominanthiv1envneutralizingdeterminantfollowingtrimerimmunization
AT odellsijy structurallyrelatedbutgeneticallyunrelatedantibodylineagesconvergeonanimmunodominanthiv1envneutralizingdeterminantfollowingtrimerimmunization
AT mascolajohnr structurallyrelatedbutgeneticallyunrelatedantibodylineagesconvergeonanimmunodominanthiv1envneutralizingdeterminantfollowingtrimerimmunization
AT leekellyk structurallyrelatedbutgeneticallyunrelatedantibodylineagesconvergeonanimmunodominanthiv1envneutralizingdeterminantfollowingtrimerimmunization
AT karlssonhedestamgunillab structurallyrelatedbutgeneticallyunrelatedantibodylineagesconvergeonanimmunodominanthiv1envneutralizingdeterminantfollowingtrimerimmunization
AT wyattrichardt structurallyrelatedbutgeneticallyunrelatedantibodylineagesconvergeonanimmunodominanthiv1envneutralizingdeterminantfollowingtrimerimmunization
AT panceramarie structurallyrelatedbutgeneticallyunrelatedantibodylineagesconvergeonanimmunodominanthiv1envneutralizingdeterminantfollowingtrimerimmunization